Menu Back to Global-Forum-for-Qualified-Persons-for-Pharmacovigilance-QPPV

Overview

The DIA Global QPPV Forum is a must-attend conference for anyone involved in pharmacovigilance. With a focus on the most pressing issues facing the industry today, this year's topics include global QPPV challenges, trends requiring QPPV awareness, and the impact of modern technology on the field. In addition, we will continue our popular 'QPPV talks' - quick, inpirational sessions that provide practical insight into real-world cases.

With input from regulators and industry leaders from around the world, this conference promises to provide valuable insights into the most pressing issues facing QPPVs today - and don't forget our 'Hot Topics' session!

So join us at the DIA Global QPPV Forum to network with peers, gain valuable insights, and stay ahead of the curve in the ever-evolving role.


Why should you attend this conference?

 

Featured

Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!

Exhibits

Learn more

Who should attend?

  • Global QPPVs/ Deputies
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/Leaders
  • Auditors
  • Medical and Regulatory Affairs Experts
  • Aspiring PV Specialists/QPPVs

Program Committee

  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Patient Safety Director, EU QPPV
    Almirall, S.A., Spain
  • Magnus  Ysander, MD
    Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
    AstraZeneca, Sweden
  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director PV, Managing partner
    DADA Consultancy B.V., Netherlands
  • Shahinaz  Badr
    Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
    Pharma Quality Europe, United Arab Emirates
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
    Abbvie, United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Katarzyna  Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Kiernan  Trevett, MSc
    Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality Assurance Process GVP
    Roche, United Kingdom
  • Claire  Longman, MSc
    Claire Longman, MSc Expert Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
    Switzerland
Load More

Contact us

Registration Questions?

Send Email
+41 61 225 51 51

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download